Medtide (HKG:3880) named Ding Lijun as its chief financial officer effective Friday, according to a same-day Hong Kong bourse filing.
Ding was previously the CFO of Inventronics (Hangzhou) from February 2025 to July 2026, the peptide-focused CRDMO said.